News

Ex-nurse jailed for life after 'playing God' and injecting man in backside with deadly drug
Darren Harris, 58, plunged a syringe loaded with powerful muscle-paralysing drug rocuronium into the backside of 65-year-old ...
ImPact Biotech Announces New Data Presentations at AUA 2025 Highlighting Safety and Efficacy of Padeliporfin VTP
Company to present updated preliminary results from ENLIGHTED Phase 3 Study in LG UTUC -- Additional podium presentation to provide updates ...
Pharmaceutical Technology on MSN1d
FDA approves Biocon Biologics’ bevacizumab biosimilar for cancer
Biocon Biologics has gained approval from the US Food and Drug Administration (FDA) for the intravenous use of Jobevne ...
Kennedy tours epicenter of US measles outbreak to promote anti-science quackery
Health Secretary Kennedy, America’s top anti-vaccine zealot, tours measles-ravaged regions while cynically consoling families ...
Argenx announces FDA approval of Vyvgart self-injection option
Argenx (ARGX) announced that the U.S. Food and Drug Administration approved a new option for patients to self-inject VYVGART Hytrulo with a ...
FDA to phase out animal testing requirement, adopt AI methods
The U.S. Food and Drug Administration said on Thursday that it will be phasing out animal testing requirement for monoclonal ...
Study provides scaffold to selectively target drug breakdown process
Cytochrome P450 (CYP) proteins are responsible for breaking down more than 80% of all Food and Drug Administration ...
Novavax Shares Tumble After U.S. Health Secretary Raises Concerns Over COVID Shot's Efficacy
The U.S. Food and Drug Administration, an agency that is part of the U.S. Department of Health and Human Services, missed its ...
Key mechanism behind prostate cancer drug resistance reveals potential new treatment strategy
A team of University of Kentucky Markey Cancer Center researchers has found the mechanism that grants prostate cancer ...
Multiple Sclerosis News Today3d
Non-drug therapy costs high for MS patients in Austria, study finds
Non-drug therapy costs for people with MS in Austria can be high, averaging €136 per month, according to a study.
Anti-vaccine sentiment may derail vaccines already awaiting FDA approval, experts fear
Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail ...
Taiwan News6d
Global Real World Evidence Solutions Market to Reach US$ 9.1 Billion by 2032, Growing at a CAGR of 15.5% From US$ 2.5 Billion in 2023
The global real world evidence (RWE) solutions market is on a robust growth trajectory, expected to surge from US$ 2.5 billion in 2023 to US$ 9.1 billion by 2032, registering a compound annual growth ...